EU-MEDICAL_DEVICES_REGULATION-ANX_I_SEC_10

Medical Devices Regulation - Hazardous Substances

EU. Hazardous Substances for Purposes of Medical Devices Regulation 2017/745/EU, 5 May 2017, as amended by Regulation 2020/561/EU, 24 April 2020

This list contains hazardous substances for purposes of the Medical Devices Regulation (MDR), based on the legislation's Annex I general safety and performance requirements, including for chemical, physical and biological properties. Specifically, the non-exhaustive database is derived from: Table 3 of Annex VI to CLP, REACH Candidate List of SVHCs, and Directive 2000/54/EC's Annex III (Biological Agents list).

RELEVANT LEGISLATION
Last updated 12 rujna 2024. Database contains 4917 unique substances/entries.
Filter the list

Stranica 39 od 99
50 Broj stavki po stranici
Prikaz 1.901 - 1.950 od 4.917 rezultata.
Substance Name
EC No.
CAS No.
EU CLP (1272/2008)
EU REACH: List of SVHC
EU_BA Directive 2000/54/EC
 
bromophos-ethyl (ISO); O-4-bromo-2,5-dichlorophenyl; O,O-diethyl phosphorothioate
225-399-0
4824-78-6
Acute Tox. 3; Acute Tox. 4
Details
bromoxynil (ISO) 3,5-dibromo-4-hydroxybenzonitrile; bromoxynil phenol
show/hide
2,6-dibromo-4-cyanophenyl butyrate EC / List no: 223-374-9 | CAS no: 3861-41-4
2,6-dibromo-4-cyanophenyl heptanoate EC / List no: 260-300-4 | CAS no: 56634-95-8
3,5-dibromo-4-hydroxybenzonitrile EC / List no: 216-882-7 | CAS no: 1689-84-5
2,6-dibromo-4-cyanophenyl octanoate EC / List no: 216-885-3 | CAS no: 1689-99-2
216-882-7
1689-84-5
Repr. 2; Acute Tox. 2; Acute Tox. 3; Skin Sens. 1
Details
bromoxynil heptanoate (ISO); 2,6-dibromo-4-cyanophenyl heptanoate
260-300-4
56634-95-8
Repr. 2; Acute Tox. 4; Skin Sens. 1
Details
bromoxynil octanoate (ISO); 2,6-dibromo-4-cyanophenyl octanoate
216-885-3
1689-99-2
Repr. 2; Acute Tox. 3; Acute Tox. 4; Skin Sens. 1
Details
bronopol (INN); 2-bromo-2-nitropropane-1,3-diol
200-143-0
52-51-7
Acute Tox. 4; STOT SE 3; Skin Irrit. 2; Eye Dam. 1
Details
brucine nitrate
227-317-9
5786-97-0
Acute Tox. 2
Details
brucine sulphate
225-432-9
4845-99-2
Acute Tox. 2
Details
brucine; 2,3-dimethoxystrychnine
206-614-7
357-57-3
Acute Tox. 2
Details
bufa-4,20,22-trienolide, 6-(acetyloxy)-3-(β-D-glucopyranosyloxy)-8,14-dihydroxy-, (3β, 6β)-; red squill; scilliroside
208-077-4
507-60-8
Acute Tox. 2
Details
bufencarb (ISO); reaction mass of 3-(1-methylbutyl)phenyl N-methylcarbamate and 3-(1-ethylpropyl)phenyl N-methylcarbamate
620-359-2
8065-36-9
Acute Tox. 3
Details
Bumetrizole (UV-326)
223-445-4
3896-11-5
VPVB very Persistent and very Bioaccumulative (article 57e)
Details
bunsenite
-
34492-97-2
Carc. 1A; STOT RE 1; Skin Sens. 1
Details
bupirimate (ISO); 5-butyl-2-ethylamino-6-methylpyrimidin-4-yl dimethylsulphamate
255-391-2
41483-43-6
Carc. 2; Skin Sens. 1B
Details
but-1-ene
203-449-2
106-98-9
Flam. Gas 1; Press. Gas
Details
but-2-yne-1,4-diol; 2-butyne-1,4-diol
203-788-6
110-65-6
Skin Corr. 1B; Acute Tox. 3; Acute Tox. 4; STOT RE 2; Skin Sens. 1
Details
butan-1-ol; n-butanol
200-751-6
71-36-3
Flam. Liq. 3; Acute Tox. 4; STOT SE 3; Skin Irrit. 2; Eye Dam. 1
Details
butane;butane (containing ≥ 0,1 % butadiene (203-450-8))
203-448-7
106-97-8
Flam. Gas 1; Press. Gas; Carc. 1A; Muta. 1B
Details
butane;butane (containing ≥ 0,1 % butadiene (203-450-8))
203-448-7
106-97-8
Flam. Gas 1; Press. Gas
Details
butanone oxime; ethyl methyl ketoxime; ethyl methyl ketone oxime
202-496-6
96-29-7
Carc. 1B; Acute Tox. 4; Acute Tox. 3; STOT SE 3; STOT SE 1; STOT RE 2; Skin Irrit. 2; Eye Dam. 1; Skin Sens. 1
Details
butanone; ethyl methyl ketone
201-159-0
78-93-3
Flam. Liq. 2; Eye Irrit. 2; STOT SE 3
Details
butene, mixed-1-and-2-isomers
203-452-9
107-01-7
Flam. Gas 1; Press. Gas
Details
butocarboxim (ISO); 3-(methylthio)-2-butanone O-[(methylamino)carbonyl]oxime
252-139-3
34681-10-2
Flam. Liq. 3; Acute Tox. 3; Eye Irrit. 2
Details
butroxydim (ISO); 5-(3-butyryl-2,4,6-trimethylphenyl)-2-[1-(ethoxyimino)propyl]-3-hydroxycyclohex-2-en-1-one
BUTROXYDIM; ICIA0500
414-790-3
138164-12-2
Repr. 2; Acute Tox. 4; Skin Irrit. 2
Details
butyl (dialkyloxy(dibutoxyphosphoryloxy))titanium (trialkyloxy)titanium phosphate
TILCOM CA35; TILCOM IA10; TYTAN AP 100; TYTAN CA 100; TYTAN CX 35; TYZOR IAM
401-100-0
109037-78-7
Flam. Liq. 2; Eye Irrit. 2
Details
Butyl 4-hydroxybenzoate
202-318-7
94-26-8
END Endocrine disrupting properties (Article 57(f) - human health)
Details
butyl butyrate
203-656-8
109-21-7
Flam. Liq. 3
Details
butyl chloroformate; chloroformic acid butyl ester
209-750-5
592-34-7
Flam. Liq. 3; Acute Tox. 3; Skin Corr. 1B
Details
butyl formate
209-772-5
592-84-7
Flam. Liq. 2; Eye Irrit. 2; STOT SE 3
Details
butyl glycidyl ether; butyl 2,3-epoxypropyl ether
219-376-4
2426-08-6
Flam. Liq. 3; Carc. 2; Muta. 2; Acute Tox. 4; STOT SE 3; Skin Sens. 1
Details
butyl nitrite
208-862-1
544-16-1
Flam. Liq. 2; Acute Tox. 3
Details
butylamine
203-699-2
109-73-9
Flam. Liq. 2; Acute Tox. 4; Skin Corr. 1A
Details
butyltricyclohexylstannane
230-358-5
7067-44-9
Acute Tox. 4
Details
butyraldehyde
204-646-6
123-72-8
Flam. Liq. 2
Details
butyraldehyde oxime
203-792-8
110-69-0
Acute Tox. 3; Acute Tox. 4; Eye Irrit. 2
Details
butyric acid
203-532-3
107-92-6
Skin Corr. 1B
Details
butyryl chloride
205-498-5
141-75-3
Flam. Liq. 2; Skin Corr. 1B
Details
C,C'-azodi(formamide)
204-650-8
123-77-3
Resp. Sens. 1
RSP Respiratory sensitising properties (Article 57(f)) - human health)
Details
C.I. Basic Violet 3 with ≥ 0,1 % of Michler's ketone (EC no.202-027-5);C.I. Basic Violet 3; 4-[4,4'-bis(dimethylamino) benzhydrylidene]cyclohexa-2,5-dien-1-ylidene]dimethylammonium chloride;[4-[4,4'-bis(dimethylamino) benzhydrylidene]cyclohexa-2,5-dien-1-ylidene]dimethylammonium chloride; C.I. Basic Violet 3
208-953-6
548-62-9
Carc. 1B; Acute Tox. 4; Eye Dam. 1
Details
C.I. Basic Violet 3 with ≥ 0,1 % of Michler's ketone (EC no.202-027-5);C.I. Basic Violet 3; 4-[4,4'-bis(dimethylamino) benzhydrylidene]cyclohexa-2,5-dien-1-ylidene]dimethylammonium chloride;[4-[4,4'-bis(dimethylamino) benzhydrylidene]cyclohexa-2,5-dien-1-ylidene]dimethylammonium chloride; C.I. Basic Violet 3
208-953-6
548-62-9
C Carcinogenic (article 57a)
Details
C.I. Basic Violet 3 with ≥ 0,1 % of Michler's ketone (EC no.202-027-5);C.I. Basic Violet 3; 4-[4,4'-bis(dimethylamino) benzhydrylidene]cyclohexa-2,5-dien-1-ylidene]dimethylammonium chloride;[4-[4,4'-bis(dimethylamino) benzhydrylidene]cyclohexa-2,5-dien-1-ylidene]dimethylammonium chloride; C.I. Basic Violet 3
208-953-6
548-62-9
Carc. 2; Acute Tox. 4; Eye Dam. 1
Details
C.I. Disperse Yellow 3; N-[4-[(2-hydroxy-5-methylphenyl)azo]phenyl]acetamide
220-600-8
2832-40-8
Carc. 2; Skin Sens. 1
Details
C.I. Solvent Yellow 14; 1-phenylazo-2-naphthol
212-668-2
842-07-9
Carc. 2; Muta. 2; Skin Sens. 1
Details
C12-14-tert-alkyl ammonium 1-amino-9,10-dihydro-9,10-dioxo-4-(2,4,6-trimethylanilino)-anthracen-2-sulfonate
ORASOL BLAU 761B
414-110-5
1379678-96-2
Eye Dam. 1
Details
C12-14-tert-alkylamine, methylphosphonic acid salt
CD 23-404
404-750-3
119415-07-5
Acute Tox. 4; Skin Corr. 1B
Details
C8-10 alkyl dimethyl hydroxyethyl ammoniumchloride (chain < C8: <3 %, chain = C8: 15 %-70 %, chain = C10: 30 %- 85 %, chain > C10: <3 %)
417-360-3
1379678-84-8
Acute Tox. 4; Skin Irrit. 2
Details
C8-18 alkylbis(2-hydroxyethyl)ammonium bis(2-ethylhexyl)phosphate
INTERSEPT
404-690-8
68132-19-4
Acute Tox. 3; Skin Corr. 1B; Skin Sens. 1
Details
cadmium carbonate
208-168-9
513-78-0
Carc. 1B; Muta. 1B; Acute Tox. 4; STOT RE 1
C Carcinogenic (article 57a)
M Mutagen (article 57b)
HH2 Specific target organ toxicity after repeated exposure (Article 57(f) - human health)
Details
cadmium chloride
show/hide
cadmium chloride (CdCl2), hydrate (2:5) EC / List no: 640-998-0 | CAS no: 7790-78-5
233-296-7
10108-64-2
Carc. 1B; Muta. 1B; Repr. 1B; Acute Tox. 2; Acute Tox. 3; STOT RE 1
C Carcinogenic (article 57a)
M Mutagen (article 57b)
R Toxic for reproduction (article 57c)
HH2 Specific target organ toxicity after repeated exposure (Article 57(f) - human health)
Details
Cadmium chloride, hydrate (2:5)
640-998-0
7790-78-5
C Carcinogenic (article 57a)
M Mutagen (article 57b)
R Toxic for reproduction (article 57c)
HH2 Specific target organ toxicity after repeated exposure (Article 57(f) - human health)
Details
cadmium compounds, with the exception of cadmium sulphoselenide (xCdS.yCdSe), reaction mass of cadmium sulphide with zinc sulphide (xCdS.yZnS), reaction mass of cadmium sulphide with mercury sulphide (xCdS.yHgS), and those specified elsewhere in this Annex
-
-
Acute Tox. 4
Details
Stranica 39 od 99
50 Broj stavki po stranici
Prikaz 1.901 - 1.950 od 4.917 rezultata.

Export search results to: